{"id":"W2349813309","doi":"10.1097/qai.0000000000001069","title":"Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults","year":2016,"lang":"en","type":"article","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"AbbVie Canada; Janssen Canada; Merck Canada; Shionogi; Sanofi; Novo Nordisk; Gilead Sciences; Daiichi Sankyo Europe; AIDS Healthcare Foundation; Bristol-Myers Squibb","keywords":"Elvitegravir; Tenofovir alafenamide; Medicine; Emtricitabine; Cobicistat; Hepatitis B; Virology; Hepatitis B virus; Coinfection; Internal medicine; Gastroenterology; Viral load; Human immunodeficiency virus (HIV); Lamivudine; Virus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001693011,0.0003370903,0.0008010356,0.0001984726,0.000288183,0.000375683,0.0002444982,0.0008629271,0.00340572],"category_scores_gemma":[0.003180013,0.0001407974,0.0005897122,0.000194447,0.000245567,0.0004015241,0.0001083301,0.0008978226,0.0004581356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002582683,"about_ca_system_score_gemma":0.0003465156,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008090609,"about_ca_topic_score_gemma":0.0006607043,"domain_scores_codex":[0.9993575,0.0003700799,0.00009684089,0.00005504415,0.0000859891,0.00003446678],"domain_scores_gemma":[0.9969804,0.001432375,0.0007898402,0.000146414,0.0003175593,0.0003333745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5542644,0.01774883,0.03867199,0.001902852,0.001983147,0.0008175616,0.0003870951,0.0006960191,0.01362628,0.0001274198,0.01337395,0.3564005],"study_design_scores_gemma":[0.1188527,0.6572083,0.1912215,0.0003053486,0.002636671,0.001570136,0.0002171017,0.001551235,0.01268726,0.0002498079,0.01342045,0.0000794645],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825936,0.008406455,0.000458863,0.001534131,0.0005421552,0.001054459,0.002116614,0.00007022473,0.003223515],"genre_scores_gemma":[0.9912642,0.002812516,0.0008470253,0.001068301,0.001141942,0.0003081308,0.001004871,0.00001203513,0.001540871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00340572,"threshold_uncertainty_score":0.01139325,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01246011699389881,"score_gpt":0.2537831073013661,"score_spread":0.2413229903074672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}